Evidence map›Paper›PMID 40149664›Full record

ArticleBiomedicines2025

Astilbin Alleviates Radiation-Induced Pulmonary Fibrosis via

Zhiling Shi, Jing Liu, Jing Qin, Xian Liang, Xue Ou, Tingting Zhang, Xueting Yan, Qianxin Hu, Weimei Huang, Kai Hu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhiling ShiDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Jing LiuDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Jing QinDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Xian LiangDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Xue OuDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Tingting ZhangDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Xueting YanDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Qianxin HuDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Weimei HuangDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Kai HuDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.ORCID 0000-0003-4990-0395

Funding

Guangxi Natural Science Foundation No. 2024GXNSFBA010244Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation No. 2024GXNSFDA010042Natural Science Foundation of China No. 82060019Research Project on Innovative Supportive Therapies for Cancer NO. cphcf-2022-108
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

astilbinepithelial–mesenchymal transitionradiation-induced pulmonary fibrosisradioprotectionSmad7

Identifiers

PMID40149664
PMCPMC11939908

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.